Page last updated: 2024-12-10
6-iodoamiloride
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 3085183 |
CHEMBL ID | 1909813 |
CHEMBL ID | 1962825 |
SCHEMBL ID | 9852471 |
MeSH ID | M0093354 |
Synonyms (10)
Synonym |
---|
6-iodoamiloride |
SCHEMBL9852471 |
60398-23-4 |
pyrazinecarboxamide, 3,5-diamino-n-(aminoiminomethyl)-6-iodo- |
3,5-diamino-n-(aminoiminomethyl)-6-iodopyrazinecarboxamide |
CHEMBL1909813 , |
bdbm50356154 |
FT-0621173 |
CHEMBL1962825 |
DTXSID80209150 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (75.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.09
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.09) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (12.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |